Haleon HLN
NYSE HLN
$9.88 +0.01 (+0.10%)
At close: Aug 20, 2026 · 2:08 PM UTC

Haleon (HLN) Net Income Growth (1y) (2022 - 2023)

Haleon (HLN) Net Income Growth (1y) (2022 - 2023) Analysis & Trends

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Net Income Growth (1y) (Qtr)
1 Haleon 43.89 Bn 42.93 Bn - -
2 Teva Pharmaceutical Industries 42.98 Bn 39.33 Bn 2.15 Bn -304.98%
3 Zoetis 31.54 Bn 29.86 Bn 1.05 Bn -5.04%
4 Takeda Pharmaceutical 28.61 Bn 22.81 Bn 5.10 Bn -105.67%
5 United Therapeutics 22.15 Bn 19.48 Bn 683.80 Mn 7.59%
6 Viatris 18.75 Bn 17.86 Bn 1.46 Bn -2,482.61%
7 Neurocrine Biosciences 15.56 Bn 15.17 Bn 935.80 Mn 34.33%
8 Elanco Animal Health 11.74 Bn 11.21 Bn 798.00 Mn 390.91%
9 Dr Reddys Laboratories 10.11 Bn 9.95 Bn - -
10 Alkermes 8.11 Bn 7.46 Bn 397.90 Mn -99.40%

Historic Data

Download Data
DateValue
Dec 31, 2023 5.76%
Dec 31, 2022 -0.63%